首页> 美国卫生研究院文献>other >Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

【2h】

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

机译：囊性纤维化跨膜电导调节剂（CFTR）调节剂对小剂量布洛芬治疗的儿童囊性纤维化患者的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:This study was undertaken to determine if a clinically relevant drug-drug interaction occurred between ibuprofen and lumacaftor/ivacaftor.

机译：背景：这项研究是为了确定布洛芬与lumacaftor / ivacaftor之间是否发生了临床相关的药物相互作用。

著录项

期刊名称 other
作者
Brittany A. Bruch; Sachinkumar K. Singh; Laura J. Ramsey; Timothy D. Starner;
展开▼
作者单位

展开▼
年(卷),期 -1(53),8
年度 -1
页码 1035–1039
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
cystic fibrosis drug interactions pharmacology;

机译：囊性纤维化;药物相互作用;药理学;

相似文献

外文文献
中文文献
专利

1. Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high‐dose ibuprofen therapy in pediatric cystic fibrosis patients [J] . Bruch Brittany A., Singh Sachinkumar B., Ramsey Laura J., Pediatric Pulmonology . 2018,第8期

机译：囊性纤维化跨膜电导调节剂（CFTR）调节剂对小儿囊性纤维化患者高剂量布洛芬治疗的影响
2. Cystic Fibrosis Foundation Pulmonary Guidelines Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis [J] . Ren Clement L., Morgan Rebecca L., Oermann Christopher, Annals of the American Thoracic Society . 2018,第3期

机译：囊性纤维化基础肺指导利用囊性纤维化跨膜电导调节剂调节剂治疗患者囊性纤维化
3. Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center [J] . Wright Brittany A., Singh Sachinkumar B., Schultz Jordan L., Pediatric Pulmonology . 2019,第10期

机译：药房服务对小儿囊性纤维化中心处方规定囊性纤维化跨膜电导调节剂的影响
4. Cystic fibrosis transmembrane conductance regulator gene mutations cause 'black' pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis [C] . A. L. BRODERICK, H. WITTENBURG, M. A. LYONS, Falk Symposium . 2004

机译：囊性纤维化跨膜电导调节剂基因突变引起'黑色'颜料胆结石形成：来自小鼠模型的新见解，以及对囊性纤维化治疗干预的影响
5. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies in Cystic Fibrosis: A Retrospective Evaluation of a Nationwide Specialty Pharmacy Database [D] . Mehta, Zumi . 2020

机译：囊性纤维化跨膜电导调节剂调节剂患者囊性纤维化：全国特色药房数据库的回顾性评估
6. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function [O] . Shuzhong Zhang, Chandra L. Shrestha, Benjamin T. Kopp -1

机译：囊性纤维化跨膜电导调节剂（CFTR）调节剂对囊性纤维化巨噬细胞功能有不同的影响
7. A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis [O] . Alton, Eric Wfw, Armstrong, David K, Ashby, Deborah, 2016

机译：一项随机，双盲，安慰剂对照试验，对囊性纤维化患者反复雾化非病毒囊性纤维化跨膜传导调节因子（CFTR）基因治疗

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

摘要

著录项

相似文献

相关主题

期刊订阅